Brazil health regulator Anvisa on Wednesday allowed resumption of latestage Brazilian clinical trials for China's Sinovac COVID19 vaccine, which had been suspended due to a study subject's death that was registered in Sao Paulo as a suicide.from Top Business News- News18.com
via IFTTT
No comments:
Post a Comment